|
|
Résultats pour
 brevets
1.
|
ACTIVITY OF RECOMBINANT EQUINE FOLLICLE STIMULATING HORMONE
| Numéro de document |
02707352 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-11-28 |
| Date de disponibilité au public |
2009-06-11 |
| Date d'octroi |
2020-10-27 |
| Propriétaire |
ASPENBIO PHARMA, INC. (USA)
|
| Inventeur(s) |
- Colgin, Mark
- Boime, Irving
- Roser, Janet
- Niswender, Kory
|
Abrégé
The present invention provides methods of producing biologically active recombinant eFSH analogs and methods of increasing reproduction in mammals, particularly equine, using recombinant eFSH analogs. Also provided are methods of producing biologically active single chain recombinant eFSH. The recombinant eFSH analogs of the present invention increase superovulation, follicular development, embryo development, and reproductive efficiency in horses, cattle and other ungulates.
Classes IPC ?
- C07K 14/59 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. hCG [gonadotrophine chorionique humaine] Hormone lutéinisante [LH]Hormone thyséotrope [TSH]
- A61K 35/55 - Glandes non prévues dans les groupes , p. ex. glandes thyroïdes, parathyroïdes ou pinéales
- A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
- A61K 38/24 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. HCGHormone lutéinisante [LH]Hormone thyréotrope [TSH]
- A61P 15/08 - Médicaments pour le traitement des troubles génitaux ou sexuelsContraceptifs pour les troubles gonadiques ou pour augmenter la fertilité, p. ex. inducteurs d'ovulation ou de spermatogénèse
- C12N 15/16 - Hormones
|
2.
|
ACTIVITY OF RECOMBINANT EQUINE FOLLICLE STIMULATING HORMONE
| Numéro d'application |
US2008085072 |
| Numéro de publication |
2009/073574 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-11-28 |
| Date de publication |
2009-06-11 |
| Propriétaire |
ASPENBIO PHARMA, INC. (USA)
|
| Inventeur(s) |
- Colgin, Mark
- Boime, Irving
- Roser, Janet
- Niswender, Kory
|
Abrégé
The present invention provides methods of producing biologically active recombinant eFSH analogs and methods of increasing reproduction in mammals, particularly equine, using recombinant eFSH analogs. Also provided are methods of producing biologically active single chain recombinant eFSH. The recombinant eFSH analogs of the present invention increase superovulation, follicular development, embryo development, and reproductive efficiency in horses, cattle and other ungulates.
Classes IPC ?
- A61K 35/55 - Glandes non prévues dans les groupes , p. ex. glandes thyroïdes, parathyroïdes ou pinéales
|
3.
|
Methods for inducing superovulation in ungulates
| Numéro d'application |
12028155 |
| Numéro de brevet |
08518881 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-02-08 |
| Date de la première publication |
2008-12-18 |
| Date d'octroi |
2013-08-27 |
| Propriétaire |
AspenBio Pharma, Inc. (USA)
|
| Inventeur(s) |
- Colgin, Mark A.
- Donnelly, Richard G.
- Stroud, Brad
|
Abrégé
The present invention provides methods of producing biologically active recombinant bFSH and methods of increasing reproduction in mammals, particularly bovine, using recombinant bFSH. Also provided are methods of producing single chain recombinant bFSH. The recombinant bFSH of the present invention increases superovulation, embryo development, and reproductive efficiency in cattle and other ungulates.
Classes IPC ?
- A61K 38/24 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. HCGHormone lutéinisante [LH]Hormone thyréotrope [TSH]
- C07K 14/59 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. hCG [gonadotrophine chorionique humaine] Hormone lutéinisante [LH]Hormone thyséotrope [TSH]
|
4.
|
METHODS AND DEVICES FOR DIAGNOSIS OF APPENDICITIS
| Numéro d'application |
US2008052418 |
| Numéro de publication |
2008/097773 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-01-30 |
| Date de publication |
2008-08-14 |
| Propriétaire |
ASPENBIO PHARMA, INC. (USA)
|
| Inventeur(s) |
- Colgin, Mark, A.
- Bealer, John, F.
- Donnelly, Richard, G.
|
Abrégé
An immunoassay device and method is provided for determining the severity of appendicitis in a patient that includes testing a blood, serum or plasma sample from the patient for the quantity of MRP8/14 in the sample and comparing it with the quantity of MRP8/14 present in standard samples correlated with an appendicitis severity scoring system. Standard samples and data correlating MRP8/14 quantities present in patient samples to histologically-based appendicitis severity grades are also provided. The methods and immunoassay devices and kits of this invention are useful for managing the treatment of patients presenting with appendicitis symptoms.
Classes IPC ?
- C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
|
5.
|
COMPOSITIONS AND METHODS INCLUDING EXPRESSION AND BIOACTIVITY OF BOVINE FOLLICLE STIMULATING HORMONE
| Numéro d'application |
US2008053417 |
| Numéro de publication |
2008/098169 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-02-08 |
| Date de publication |
2008-08-14 |
| Propriétaire |
- ASPENBIO PHARMA, INC. (USA)
- DONNELLY, Richard G. (USA)
- STROUD, Brad (USA)
|
| Inventeur(s) |
Colgin, Mark A.
|
Abrégé
The present invention provides methods of producing biologically active recombinant bFSH and methods of increasing reproduction in mammals, particularly bovine, using recombinant bFSH. Also provided are methods of producing single chain recombinant bFSH. The recombinant bFSH of the present invention increases superovulation, embryo development, and reproductive efficiency in cattle and other ungulates.
Classes IPC ?
- A01K 67/02 - Obtention de vertébrés
- A61K 38/24 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. HCGHormone lutéinisante [LH]Hormone thyréotrope [TSH]
- C07K 14/59 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. hCG [gonadotrophine chorionique humaine] Hormone lutéinisante [LH]Hormone thyséotrope [TSH]
|
6.
|
COMPOSITIONS AND METHODS INCLUDING EXPRESSION AND BIOACTIVITY OF BOVINE FOLLICLE STIMULATING HORMONE
| Numéro de document |
02685437 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-02-08 |
| Date de disponibilité au public |
2008-08-14 |
| Date d'octroi |
2015-06-02 |
| Propriétaire |
ASPENBIO PHARMA, INC. (USA)
|
| Inventeur(s) |
- Colgin, Mark A.
- Donnelly, Richard G.
- Stroud, Brad
|
Abrégé
The present invention provides methods of producing biologically active recombinant bFSH and methods of increasing reproduction in mammals, particularly bovine, using recombinant bFSH. Also provided are methods of producing single chain recombinant bFSH. The recombinant bFSH of the present invention increases superovulation, embryo development, and reproductive efficiency in cattle and other ungulates.
Classes IPC ?
- C07K 14/59 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. hCG [gonadotrophine chorionique humaine] Hormone lutéinisante [LH]Hormone thyséotrope [TSH]
- A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
- A61K 38/24 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. HCGHormone lutéinisante [LH]Hormone thyréotrope [TSH]
- A61P 15/00 - Médicaments pour le traitement des troubles génitaux ou sexuelsContraceptifs
- C12N 15/16 - Hormones
|
7.
|
Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
| Numéro d'application |
10795128 |
| Numéro de brevet |
10105417 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2004-03-04 |
| Date de la première publication |
2004-12-30 |
| Date d'octroi |
2018-10-23 |
| Propriétaire |
AspenBio Pharma, Inc. (USA)
|
| Inventeur(s) |
- Mcsweeney, Kevin
- Colgin, Mark
- Newman, Diane
- Roth, Jay W.
- Hurst, Roger
|
Abrégé
This invention provides methods and kits for maintaining pregnancy in mammals. Pregnancy is maintained by administration of effective amounts of luteinizing hormone (LH) or chorionic gonadotropin (CG). Both LH and CG may be used alone, in combination with each other, or in combination with growth hormone (GH) or follicle stimulating hormone (FSH). Hormones are administered on about Day 4 to about Day 7 following insemination. Effective amounts of LH range from about 10 micrograms to about 25 milligrams, preferably about 2 to about 8 mg, and of CG range from about 100 IU (international units) to about 2000 IU. Mammals treatable by the methods of this invention include ungulates and related mammals, including bovines. Kits provided by this invention include effective amounts of one or more hormones, a device for administering the hormone(s) and instructions. This invention also provides methods for treating follicular cysts and for synchronizing ovulation in mammals using LH.
Classes IPC ?
- A61K 38/24 - Hormone folliculostimulante [FSH]Gonadotropines chorioniques, p. ex. HCGHormone lutéinisante [LH]Hormone thyréotrope [TSH]
- A61D 19/00 - Instruments ou procédés pour la reproduction ou la fertilisation
|
|